RT Journal Article
SR Electronic
T1 Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.10.21264753
DO 10.1101/2021.10.10.21264753
A1 Nicolas Franco
A1 Pietro Coletti
A1 Lander Willem
A1 Leonardo Angeli
A1 Adrien Lajot
A1 Steven Abrams
A1 Philippe Beutels
A1 Christel Faes
A1 Niel Hens
YR 2021
UL http://medrxiv.org/content/early/2021/10/14/2021.10.10.21264753.abstract
AB Several important aspects related to SARS-CoV-2 transmission are not well known due to a lack of appropriate data. However, mathematical and computational tools can be used to extract part of this information from the available data, like some hidden age-related characteristics. In this paper, we investigate age-specific differences in susceptibility to and infectiousness upon contracting SARS-CoV-2 infection. More specifically, we use panel-based social contact data from diary-based surveys conducted in Belgium combined with the next generation principle to infer the relative incidence and we compare this to real-life incidence data. Comparing these two allows for the estimation of age-specific transmission parameters. Our analysis implies the susceptibility in children to be around half of the susceptibility in adults, and even lower for very young children (preschooler). However, the probability of adults and the elderly to contract the infection is decreasing throughout the vaccination campaign, thereby modifying the picture over time.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program -- Project TransMID (NF, PC and NH, Grant Agreement 682540). This project was also funded by the European Union's Horizon 2020 Research and Innovations Programme -- Project EpiPose, Epidemic intelligence to Minimize COVID-19's Public Health, Societal and Economical Impact (NH, grant number 101003688). LW gratefully acknowledges support from the Research Foundation Flanders (FWO) (postdoctoral fellowships 1234620N). NH acknowledges funding from the Antwerp Study Center for Infectious Diseases (ASCID) and the Methusalem-Centre of Excellence consortium VAX-IDEA. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:CoMix social contact data are publicly available at http://www.socialcontactdata.org. PCR tests data are owned by Sciensano, publicly available in aggregate form at https://epistat.wiv-isp.be/covid/ while non-aggregate data can be requested via the online form https://epistat.wiv-isp.be/datarequest.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesR codes and all necessary data to run the codes (potentially aggregate) are available on GitHub at https://github.com/nicolas-franco-unamur/Next-gen. CoMix data and age-class re-aggregate PCR tests data are provided with the code. CoMix social contact data are also available via http://www.socialcontactdata.org. PCR tests data are owned by Sciensano, publicly available in aggregate form at https://epistat.wiv-isp.be/covid/ while non-aggregate data can be requested via the online form https://epistat.wiv-isp.be/datarequest. https://github.com/nicolas-franco-unamur/Next-gen http://www.socialcontactdata.org https://epistat.wiv-isp.be/covid/